miércoles, 16 de septiembre de 2026

Approval of Imaavy (Nipocalimab) and its Impact on Patients With Warm Autoimmune Hemolytic Anemia by Madaline Spencer| Published on: Sep 16, 2026

Approval of Imaavy (Nipocalimab) and its Impact on Patients With Warm Autoimmune Hemolytic Anemia by Madaline Spencer| Published on: Sep 16, 2026 Karen A. Jones, EdD, President and CEO of wAIHA Warriors, discusses the approval of Imaavy (nipocalimab) and its impact on patients with warm autoimmune hemolytic anemia (wAIHA). https://checkrare.com/approval-of-imaavy-nipocalimab-and-its-impact-on-patients-with-warm-autoimmune-hemolytic-anemia/

No hay comentarios:

Publicar un comentario